RICHARD GIACCIO: Open Payments
NPI 1659413045 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 13 payments from 6 companies in 2025. Trend: 2023 $535 · 2024 $458 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| Janssen Pharmaceuticals, Inc | 2 | $64 |
| Alkermes, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, REXULTI, Auvelity, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
